Fondaparinux or Enoxaparin for the Initial Treatment of Symptomatic Deep Venous Thrombosis

2004616 citationsJournal Article

Authors

Harry R. Büller · Academic Medical Center

Bruce L. Davidson · University of Pavia

Hervé Decousus · University of Pavia

Alexander Gallus · University of Pavia

Michael Gent · University of Pavia

Franco Piovella · University of Pavia

Martin H. Prins · University of Pavia

Gary Raskob

Abstract

Once-daily subcutaneous fondaparinux was at least as effective (not inferior) and safe as twice-daily, body weight-adjusted enoxaparin in the initial treatment of patients with symptomatic deep venous thrombosis.

Topics & Keywords

Venous Thromboembolism Diagnosis and Management Heparin-Induced Thrombocytopenia and Thrombosis Acute Myocardial Infarction Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Annals of Internal Medicine

Volume 140, Issue 11, pp. 867-873

DOI: 10.7326/0003-4819-140-11-200406010-00007

Field-Weighted Citation Impact: 37.09